First Time Loading...
N

Ningbo Menovo Pharmaceutical Co Ltd
SSE:603538

Watchlist Manager
Ningbo Menovo Pharmaceutical Co Ltd
SSE:603538
Watchlist
Price: 14.37 CNY -2.44% Market Closed
Updated: May 12, 2024

Wall Street
Price Targets

Price Targets Summary
Ningbo Menovo Pharmaceutical Co Ltd

Wall Street analysts forecast Ningbo Menovo Pharmaceutical Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Ningbo Menovo Pharmaceutical Co Ltd is 21.49 CNY with a low forecast of 21.28 CNY and a high forecast of 22.13 CNY.

Lowest
Price Target
21.28 CNY
48% Upside
Average
Price Target
21.49 CNY
50% Upside
Highest
Price Target
22.13 CNY
54% Upside
Ningbo Menovo Pharmaceutical Co Ltd Competitors:
Price Targets
ANIP
ANI Pharmaceuticals Inc
20% Upside
CGTX
Cognition Therapeutics Inc
251% Upside
DMP
Dermapharm Holding SE
56% Upside
000756
Shandong Xinhua Pharmaceutical Co Ltd
16% Downside
NOVN
Novartis AG
9% Upside
CAPLIPOINT
Caplin Point Laboratories Ltd
27% Upside
600422
KPC Pharmaceuticals Inc
12% Upside
4540
Tsumura & Co
14% Upside

Revenue
Forecast

Revenue Estimate
Ningbo Menovo Pharmaceutical Co Ltd

For the last 7 years the compound annual growth rate for Ningbo Menovo Pharmaceutical Co Ltd's revenue is 14%. The projected CAGR for the next 3 years is 13%.

14%
Past Growth
13%
Estimated Growth
Estimates Accuracy
-10%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Ningbo Menovo Pharmaceutical Co Ltd

For the last 7 years the compound annual growth rate for Ningbo Menovo Pharmaceutical Co Ltd's operating income is 17%. The projected CAGR for the next 2 years is 72%.

17%
Past Growth
72%
Estimated Growth
Estimates Accuracy
-36%
Average Miss

Net Income
Forecast

Net Income Estimate
Ningbo Menovo Pharmaceutical Co Ltd

For the last 7 years the compound annual growth rate for Ningbo Menovo Pharmaceutical Co Ltd's net income is 24%. The projected CAGR for the next 3 years is -4%.

24%
Past Growth
-4%
Estimated Growth
Estimates Accuracy
-10%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Ningbo Menovo Pharmaceutical Co Ltd's stock price target?
Price Target
21.49 CNY

According to Wall Street analysts, the average 1-year price target for Ningbo Menovo Pharmaceutical Co Ltd is 21.49 CNY with a low forecast of 21.28 CNY and a high forecast of 22.13 CNY.

What is Ningbo Menovo Pharmaceutical Co Ltd's Revenue forecast?
Projected CAGR
13%

For the last 7 years the compound annual growth rate for Ningbo Menovo Pharmaceutical Co Ltd's revenue is 14%. The projected CAGR for the next 3 years is 13%.

What is Ningbo Menovo Pharmaceutical Co Ltd's Operating Income forecast?
Projected CAGR
72%

For the last 7 years the compound annual growth rate for Ningbo Menovo Pharmaceutical Co Ltd's operating income is 17%. The projected CAGR for the next 2 years is 72%.

What is Ningbo Menovo Pharmaceutical Co Ltd's Net Income forecast?
Projected CAGR
-4%

For the last 7 years the compound annual growth rate for Ningbo Menovo Pharmaceutical Co Ltd's net income is 24%. The projected CAGR for the next 3 years is -4%.